CRP and Sepsis: Through investment in a point-of-care EuroLyser Cube1 assay, which measures quantitative values of C-reactive protein (CRP) from a drop of whole blood, we can trend a non-specific marker of inflammation and better balance the need for early antibiotic treatment for suspected sepsis with antibiotic stewardship (27).